scholarly journals Increased expression of SKP2 is an independent predictor of locoregional recurrence in cervical cancer via promoting DNA-damage response after irradiation

Oncotarget ◽  
2016 ◽  
Vol 7 (28) ◽  
pp. 44047-44061 ◽  
Author(s):  
Hung-Chun Fu ◽  
Yi-Chien Yang ◽  
Yun-Ju Chen ◽  
Hao Lin ◽  
Yu-Che Ou ◽  
...  
2006 ◽  
Vol 94 (11) ◽  
pp. 1683-1689 ◽  
Author(s):  
C Beskow ◽  
L Kanter ◽  
Å Holgersson ◽  
B Nilsson ◽  
B Frankendal ◽  
...  

2020 ◽  
Vol 295 (50) ◽  
pp. 17169-17186
Author(s):  
Mysore S. Veena ◽  
Santanu Raychaudhuri ◽  
Saroj K. Basak ◽  
Natarajan Venkatesan ◽  
Parameet Kumar ◽  
...  

We have observed overexpression of PACS-1, a cytosolic sorting protein in primary cervical tumors. Absence of exonic mutations and overexpression at the RNA level suggested a transcriptional and/or posttranscriptional regulation. University of California Santa Cruz genome browser analysis of PACS-1 micro RNAs (miR), revealed two 8-base target sequences at the 3′ terminus for hsa-miR-34a and hsa-miR-449a. Quantitative RT-PCR and Northern blotting studies showed reduced or loss of expression of the two microRNAs in cervical cancer cell lines and primary tumors, indicating dysregulation of these two microRNAs in cervical cancer. Loss of PACS-1 with siRNA or exogenous expression of hsa-miR-34a or hsa-miR-449a in HeLa and SiHa cervical cancer cell lines resulted in DNA damage response, S-phase cell cycle arrest, and reduction in cell growth. Furthermore, the siRNA studies showed that loss of PACS-1 expression was accompanied by increased nuclear γH2AX expression, Lys382-p53 acetylation, and genomic instability. PACS-1 re-expression through LNA-hsa-anti-miR-34a or -449a or through PACS-1 cDNA transfection led to the reversal of DNA damage response and restoration of cell growth. Release of cells post 24-h serum starvation showed PACS-1 nuclear localization at G1-S phase of the cell cycle. Our results therefore indicate that the loss of hsa-miR-34a and hsa-miR-449a expression in cervical cancer leads to overexpression of PACS-1 and suppression of DNA damage response, resulting in the development of chemo-resistant tumors.


2016 ◽  
Vol 42 ◽  
pp. 30-40 ◽  
Author(s):  
Hylke W. Wieringa ◽  
Ate G.J. van der Zee ◽  
Elisabeth G.E. de Vries ◽  
Marcel A.T.M. van Vugt

2020 ◽  
Vol 1867 (12) ◽  
pp. 118835
Author(s):  
Soumyadip Das ◽  
Arun Pandian Chandrasekaran ◽  
Ki-Sang Jo ◽  
Na Re Ko ◽  
Seung Jun Oh ◽  
...  

2017 ◽  
Vol 145 (1) ◽  
pp. 176-184 ◽  
Author(s):  
C.K. Ho ◽  
E.N. Kornaga ◽  
A.C. Klimowicz ◽  
E.K. Enwere ◽  
M. Dean ◽  
...  

2019 ◽  
Vol 20 (21) ◽  
pp. 5455 ◽  
Author(s):  
N. Sanjib Banerjee ◽  
Dianne Moore ◽  
Cameron J. Parker ◽  
Thomas R. Broker ◽  
Louise T. Chow

Mucosotropic human papillomaviruses (HPVs) cause prevalent anogenital infections, some of which can progress to cancers. It is imperative to identify efficacious drug candidates, as there are few therapeutic options. We have recapitulated a robust productive program of HPV-18 in organotypic raft cultures of primary human keratinocytes. The HPV E7 protein induces S phase reentry, along with DNA damage response (DDR) in differentiated cells to support viral DNA amplification. A number of small molecule inhibitors of DDR regulators are in clinical use or clinical trials to treat cancers. Here, we used our raft culture system to examine effects of inhibitors of ATR/Chk1 and ATM/Chk2 on HPV infection. The inhibitors impaired S-phase reentry and progression as well as HPV DNA amplification. The Chk1 inhibitor MK-8776 was most effective, reducing viral DNA amplification by 90–99% and caused DNA damage and apoptosis, preferentially in HPV infected cells. We found that this sensitivity was imparted by the E7 protein and report that MK-8776 also caused extensive cell death of cervical cancer cell lines. Furthermore, it sensitized the cells to cisplatin, commonly used to treat advanced cervical cancer. Based on these observations, the Chk1 inhibitors could be potential effective agents to be re-purposed to treat the spectrum of HPV infections in single or combination therapy.


Sign in / Sign up

Export Citation Format

Share Document